MSB Mesoblast Ltd
- 0.970
- +0.020+2.11%
Mesoblast Ltd News
Why Brainchip, Gold Road, Mesoblast, and Telix Shares Are Tumbling Today
Express News | Mesoblast Ltd : Piper Sandler Raises to Overweight From Neutral; Raises Target Price to $11 From $4
Why Argosy Minerals, Flight Centre, Mesoblast, and Telix Shares Are Sinking Today
Mesoblast Raised to Overweight From Neutral by Piper Sandler
Mesoblast Price Target Raised to $11.00/Share From $4.00 by Piper Sandler
Mesoblast's Gets FDA Acceptance of Application for Allogeneic Cellular Therapy
Mesoblast Shares Rise on Start of Late-Stage Trial For Low Back Pain Treatment
Express News | Mesoblast - US FDA Accepts Mesoblast's Bla Resubmission for Remestemcel-L
Mesoblast Starts Recruitment for Phase Three Low Back Pain Trial
Up 308% in 6 Months, Why Is the Mesoblast Share Price Tumbling Today?
Mesoblast Refiles Biological License Application With the Us FDA for Cell Therapy; Shares Fall 6%
What's Going on With the Mesoblast Share Price Today?
Mesoblast Resubmits Biologics License Application (BLA) With United States Food & Drug Administration (FDA) for Approval of Ryoncil in Children With Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
Express News | Mesoblast Ltd - Mesoblast Resubmits Bla With FDA for Ryoncil Approval
Mesoblast to File Biological License Application With US FDA for Cellular Therapy
ASX Growth Companies With High Insider Ownership And At Least 26% Earnings Growth
ASX Growth Leaders With High Insider Ownership To Watch
Insider Still Buying Mesoblast Shares Despite 230% Rise This Year: Should You Buy?
Why Is the Mesoblast Share Price Taking a Dive on Tuesday?
Mesoblast Could Now Generate Meaningful FY 2025 Revenue -- Market Talk
Analysis
Price Target
No Data
